Rivastigmine Treatment Report
Most Popular Brands: Exelon, Exelon Patch
What is Rivastigmine?
Rivastigmine is a cholinergic agent used for the treatment of mild to moderate dementia of the Alzheimer’s type. Rivastigmine has been available in capsule and liquid formulations since 1997. In 2006, it became the first product approved for Parkinson's disease dementia.
Reasons taken & Efficacy
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Memory problems | 10 | 0 | |||||
| Other | 2 | 0 | |||||
| Treat Parkinson's | 2 | 0 | |||||
| Attention and memory | 1 |
|
1 | ||||
| Stiffness/Spasticity | 1 | 0 |
Mouse over the table for more information
Side Effects
Dosages
Stop Reasons
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Side effects too severe
|
4 | 67% |
|
|
Did not seem to work
|
1 | 17% |
|
|
Other
|
1 | 17% |
|
|
Not indicated
|
1 | 17% |
|
Adherence, Burden & Cost See details from patient evaluations ▼
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 22, 2009.